Trials / Withdrawn
WithdrawnNCT03253029
Study of Branched-chain Amino Acids in Cancer Cachexia
Use of Branched-chain Amino Acids in Cancer Cachexia
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Western Regional Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Investigate whether supplementation with branched-chain amino acids (BCAAs) has a positive effect on cancer cachexia, as measured by the maintenance or increase in weight and lean body mass (LBM) based on body weight in kilograms (kg) and bioelectrical impedance assessment (BIA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Pure Encapsulations Branched Chain Amino Acid powder | |
| DIETARY_SUPPLEMENT | control group (no BCAAs provided) |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2017-08-17
- Last updated
- 2017-08-24
Source: ClinicalTrials.gov record NCT03253029. Inclusion in this directory is not an endorsement.